Amyris, Inc. (AMRS - Free Report) was a big mover last session, as its shares rose almost 15% on the day. The move came after the company announced that it has made the decision to extend its partnership with a global nutraceuticals market leader. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of 40 cents to 56 cents in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Amyris currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
A better-ranked stock in the biofuels space is Rentech, Inc. (RTK - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is AMRS going up? Or down? Predict to see what others think: Up or Down
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>